Drugmakers Mallinckrodt and Endo Are in Talks to Merge

 

Mallinckrodt Pharmaceuticals and Endo Inc. are exploring a potential merger that could be valued at about $7 billion, people with knowledge of the matter said.

The drugmakers, which both emerged from bankruptcies and faced litigation tied to the US opioid crisis in recent years, are discussing the terms of a transaction that would give each roughly 50% ownership of the combined entity, the people said.

https://www.bloomberg.com/news/articles/2025-03-12/drugmakers-mallinckrodt-and-endo-are-in-talks-to-merge